> Tanox reported positive Phase II data for its HIV drug candidate. Release
> Boehringer Ingelheim has received EU approval to market Aptivus for HIV. Release
> Tibotec Pharmaceuticals has announced the opening of its expanded access program (EAP) for its investigational protease inhibitor. Release
> Idera Pharmaceuticals has begun a Phase I/II trial of HYB2055 in combination with the chemotherapy agents gemcitabine and carboplatin. Release
And Finally... Health literacy experts are worried that many consumers rely too much on drug labels. Report